Differential signal requirement for upregulation of HLA-class II molecules in human lymphoma B cells.

Hematologic pathology Pub Date : 1993-01-01
H P Tony, A Brückner, M Wilhelm
{"title":"Differential signal requirement for upregulation of HLA-class II molecules in human lymphoma B cells.","authors":"H P Tony,&nbsp;A Brückner,&nbsp;M Wilhelm","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>HLA-class II molecules can be induced in low-grade non-Hodgkin B lymphoma cells by either membrane IgM cross-linking or phorbolester stimulation. The ability of phorbolesters to substitute for anti-IgM antibodies in the activation of normal and malignant human B cells has been taken as evidence for the involvement of protein kinase C (PKC) in signals transduced through membrane IgM receptors (mIgR). Here we report on freshly isolated lymphoma B cells from different patients; the cells show a distinct regulation of HLA-class II expression. In certain lymphoma cases phorbol-myristate-acetate (PMA) not only fails to up-regulate HLA-class II molecules but also inhibits anti-IgM or interleukin-4 induced class II expression. This negative signal induced by PMA seems to operate specifically in HLA-class II regulation because PMA can induce other anti-IgM mediated events like blast transformation and induction of IL-4 responsiveness at the same time. Therefore these cells support the concept of functional heterogeneity in low-grade non-Hodgkin lymphoma and may represent a differentiation stage where anti-IgM antibodies and phorbolesters influence the regulation of HLA-class II expression in a contrary direction.</p>","PeriodicalId":77160,"journal":{"name":"Hematologic pathology","volume":"7 2","pages":"79-90"},"PeriodicalIF":0.0000,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematologic pathology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

HLA-class II molecules can be induced in low-grade non-Hodgkin B lymphoma cells by either membrane IgM cross-linking or phorbolester stimulation. The ability of phorbolesters to substitute for anti-IgM antibodies in the activation of normal and malignant human B cells has been taken as evidence for the involvement of protein kinase C (PKC) in signals transduced through membrane IgM receptors (mIgR). Here we report on freshly isolated lymphoma B cells from different patients; the cells show a distinct regulation of HLA-class II expression. In certain lymphoma cases phorbol-myristate-acetate (PMA) not only fails to up-regulate HLA-class II molecules but also inhibits anti-IgM or interleukin-4 induced class II expression. This negative signal induced by PMA seems to operate specifically in HLA-class II regulation because PMA can induce other anti-IgM mediated events like blast transformation and induction of IL-4 responsiveness at the same time. Therefore these cells support the concept of functional heterogeneity in low-grade non-Hodgkin lymphoma and may represent a differentiation stage where anti-IgM antibodies and phorbolesters influence the regulation of HLA-class II expression in a contrary direction.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人淋巴瘤B细胞hla II类分子上调的差异信号需求。
hla II类分子可以通过膜IgM交联或磷酸酯刺激在低级别非霍奇金B淋巴瘤细胞中诱导。在正常和恶性的人B细胞活化过程中,磷酯替代抗IgM抗体的能力被认为是蛋白激酶C (PKC)参与通过膜IgM受体(mIgR)转导的信号的证据。在这里,我们报告了来自不同患者的新分离的淋巴瘤B细胞;细胞表现出明显的hla II类表达调控。在某些淋巴瘤病例中,磷酸肉豆蔻酸酯(PMA)不仅不能上调hla II类分子,还能抑制抗igm或白细胞介素-4诱导的II类分子的表达。PMA诱导的这种负信号似乎在hla II类调节中特异性起作用,因为PMA可以同时诱导其他抗igm介导的事件,如blast转化和诱导IL-4反应性。因此,这些细胞在低级别非霍奇金淋巴瘤中支持功能异质性的概念,可能代表了一个分化阶段,在这个阶段,抗igm抗体和pholbol酯会以相反的方向影响hla - II类表达的调节。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Topobiology in hematopoiesis. Progress in antisense therapeutics. Ex vivo expansion of hematopoietic progenitor cells in human cord blood: an effect enhanced by cord blood serum. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1